Advanced search
Publication Cover
Journal of Medical Economics Volume 22, 2019 - Issue 1
Submit an article Journal homepage
2,880
Views
9
CrossRef citations to date
0
Altmetric
Rheumatology

Cost-effectiveness analysis of secukinumab in ankylosing spondylitis from the Canadian perspective

Ron GoereeGoeree Consulting Ltd and Professor Emeritus, McMaster University, Hamilton, Ontario, Canada; Correspondence[email protected]
View further author information
,
Sima Chiva-RazaviNovartis Pharmaceuticals Canada Inc., Dorval, Quebec, Canada; View further author information
,
Praveen GundaNovartis Product Life Cycle Services-NBS, Novartis Healthcare Private Limited, Hyderabad, India; View further author information
,
Minal JainNovartis Product Life Cycle Services-NBS, Novartis Healthcare Private Limited, Hyderabad, India; View further author information
&
Steffen M. JuglNovartis Pharma AG, Basel, SwitzerlandView further author information
Pages 45-52 | Received 26 Jul 2018, Accepted 11 Oct 2018, Published online: 13 Nov 2018

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Fabiola Atzeni, Antonio Carriero, Laura Boccassini & Salvatore D’Angelo. (2021) Anti-IL-17 Agents in the Treatment of Axial Spondyloarthritis. ImmunoTargets and Therapy 10, pages 141-153.
Read now
Timo Purmonen, Kari Puolakka, Dinesh Mishra, Praveen Gunda & Janne Martikainen. (2019) Cost-effectiveness of secukinumab compared to other biologics in the treatment of ankylosing spondylitis in Finland. ClinicoEconomics and Outcomes Research 11, pages 159-168.
Read now
Murat Torgutalp & Denis Poddubnyy. (2019) IL-17 inhibition in axial spondyloarthritis: current and future perspectives. Expert Opinion on Biological Therapy 19:7, pages 631-641.
Read now

Articles from other publishers (6)

G. Adami, L. Idolazzi, C. Benini, E. Fracassi, A. Carletto, O. Viapiana, D. Gatti, M. Rossini & A. Fassio. (2023) Secukinumab retention rate is greater in patients with psoriatic arthritis presenting with axial involvement. Reumatismo 75:1.
Crossref
Peng Wang, Shuo Zhang, Binwu Hu, Weijian Liu, Xiao Lv, Songfeng Chen & Zengwu Shao. (2021) Efficacy and safety of interleukin-17A inhibitors in patients with ankylosing spondylitis: a systematic review and meta-analysis of randomized controlled trials. Clinical Rheumatology 40:8, pages 3053-3065.
Crossref
David F. L. Liew, Jonathan Dau & Philip C. Robinson. (2021) Value-Based Healthcare in Rheumatology: Axial Spondyloarthritis and Beyond. Current Rheumatology Reports 23:6.
Crossref
Quang A. LeJenny H. KangSun LeeDimittri Delevry. (2020) Cost-Effectiveness of Treatment Strategies with Biologics in Accordance with Treatment Guidelines for Ankylosing Spondylitis: A Patient-Level Model. Journal of Managed Care & Specialty Pharmacy 26:10, pages 1219-1231.
Crossref
Prabjit Ajrawat, Zahi Touma, Ismail Sari, Cameron Taheri, Juan Pablo Diaz Martinez & Nigil Haroon. (2020) Effect of TNF‐inhibitor therapy on spinal structural progression in ankylosing spondylitis patients: A systematic review and meta‐analysis. International Journal of Rheumatic Diseases 23:6, pages 728-743.
Crossref
Dam Kim, Hyojin Kim, SeongHa Cho & Min‐Chan Park. (2019) A cost per responder analysis of secukinumab vs adalimumab for the treatment of ankylosing spondylitis from the Korean perspective. International Journal of Rheumatic Diseases 22:9, pages 1630-1637.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.